ELOF1 抗体 (AA 8-57)
Quick Overview for ELOF1 抗体 (AA 8-57) (ABIN6747932)
抗原
See all ELOF1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 8-57
-
特异性
- Human ELOF1
-
预测反应
- Percent identity by BLAST analysis: Human, Mouse, Rat, Dog, Bovine, Xenopus (100%) Zebrafish (85%).
-
纯化方法
- Immunoaffinity purified
-
免疫原
-
Synthetic peptide located between aa8-57 of human ELOF1 (P60002, NP_115753). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Galago, Marmoset, Mouse, Rat, Hamster, Elephant, Panda, Dog, Bovine, Bat, Horse, Pig, Opossum, Guinea pig, Platypus, Xenopus (100%), Frog (92%), Trout, Salmon, Smelt, Sablefish, Stickleback, Pufferfish, Zebrafish, Beetle (85%).
Type of Immunogen: Synthetic peptide
-
-
anti-Elongation Factor 1 Homolog (ELOF1) (AA 1-83) antibody
ELOF1 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 4F6 unconjugated
anti-Elongation Factor 1 Homolog (ELOF1) (Internal Region) antibodyELOF1 适用: 人, 小鼠, 大鼠 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor 1 Homolog (ELOF1) (C-Term) antibodyELOF1 适用: 人 WB, ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor 1 Homolog (ELOF1) (C-Term) antibodyELOF1 适用: 人, 小鼠, 大鼠, Cow, 犬, 豚鼠, 马, 斑马鱼, Bat, Hamster, 猴, Pig, 非洲爪蟾 WB 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor 1 Homolog (ELOF1) (Middle Region) antibodyELOF1 适用: 人, 小鼠, 大鼠, Cow, 犬, 豚鼠, 马, 斑马鱼, 山羊, Saccharomyces cerevisiae WB 宿主: 兔 Polyclonal unconjugated
anti-Elongation Factor 1 Homolog (ELOF1) (N-Term) antibodyELOF1 适用: 人, 小鼠, 大鼠, Cow, 犬, 豚鼠, 马, 斑马鱼 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
说明
-
Target Species of Antibody: Human
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Distilled water
-
浓度
- Lot specific
-
缓冲液
- Lyophilized from PBS with 2 % sucrose
-
注意事项
- Avoid repeat freeze-thaw cycles.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
